A comparison of medical records reveals people who took SSRI antidepressants, specifically fluoxetine (Prozac), were less likely to die of COVID-19 than a matched control group. The findings add to a growing body of evidence that SSRIs may have beneficial effects against the worst symptoms of coronavirus.
MediTrain, a new app-based program that uses a closed-loop algorithm to tailor the length of meditation sessions to a person's ability, can improve memory and attention in younger people.
A new dual-drug therapy for alcohol use disorder appears to be effective and has fewer side effects or complications compared to other medications used to treat AUD.
UCSF researchers report maternal stress could impact the development of a child's parasympathetic nervous system, both in utero and after birth. Additionally, children whose mothers were stressed during pregnancy smile less, are less engaged and have a diminished ability to regulate emotions.
New abortion bans and restrictions could result in life-threatening consequences for women of childbearing age with epilepsy, multiple sclerosis, and migraine due to restrictions placed on their ability to access life-saving medications. Patients in states with strict abortion restrictions are reporting they are unable to access teratogenic drugs to treat their conditions, including methotrexate, as the medications can induce abortion.
Patients who experienced cognitive impairments, or brain fog, following COVID-19 infection had abnormalities in their cerebrospinal fluid. Researchers say the overstimulation of the immune system as a result of COVID may be the cause of cognitive deficits.
DNA markers in cells of patients with major depressive disorder appear to be two years older than markers in cells of people without the mental health disorder.
Retinal scans can help researchers detect Alzheimer's disease and track its progression in those with the APOE4 genetic risk factor for the neurodegenerative disorder. The scans can detect blood vessel deterioration linked to the genetic biomarker.
A new study supports olfactory testing as an early method to detect those at risk of developing dementia.
Researchers say failure to follow principles of population science can skew results of brain imaging studies.